Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-22

FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)

View source ↗

Summary

The FDA approved a supplemental application for AUVI-Q, the epinephrine auto-injector from Kaleo, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUVI-Q (Epinephrine)

Snippet

SUPPL AP for AUVI-Q (EPINEPHRINE)